PureTech Health plc Files Mid-Year 6-K Report
Ticker: PTCHF · Form: 6-K · Filed: Aug 28, 2024 · CIK: 1782999
| Field | Detail |
|---|---|
| Company | Puretech Health PLC (PTCHF) |
| Form Type | 6-K |
| Filed Date | Aug 28, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, interim-report, sec-filing
TL;DR
PureTech Health's 6-K shows H1 2024 financials vs H1 2023, with detailed equity breakdown.
AI Summary
PureTech Health plc filed a 6-K report for the period ending June 30, 2024. The filing includes financial data for the six months ended June 30, 2024, and comparative periods. It details various equity components and reserves as of December 31, 2022, and financial results for the first half of 2024 versus 2023.
Why It Matters
This filing provides investors with an update on PureTech Health's financial position and performance for the first half of 2024, allowing for assessment of trends and operational progress.
Risk Assessment
Risk Level: low — This is a routine financial filing providing historical data and does not introduce new risks.
Key Numbers
- June 30, 2024 — Reporting Period End Date (Indicates the end of the financial period covered by the report.)
- June 30, 2023 — Comparative Period End Date (Used for comparing financial performance against the prior year.)
- December 31, 2022 — Balance Sheet Date (Date as of which detailed equity components are reported.)
Key Players & Entities
- PureTech Health plc (company) — Filer of the report
FAQ
What is the primary purpose of this 6-K filing?
The primary purpose is to provide the SEC with interim financial information for the period ending June 30, 2024, including comparative data.
What specific financial periods are covered in the filing?
The filing covers the six months ended June 30, 2024, and June 30, 2023, as well as balance sheet information as of December 31, 2022.
What type of company is PureTech Health plc?
PureTech Health plc is classified under Pharmaceutical Preparations (SIC code 2834).
Where is PureTech Health plc's business address located?
PureTech Health plc's business address is located at 6 Tide Street, Suite 400, Boston, MA 02210.
What are some of the equity components detailed in the filing?
The filing details components such as Issued Capital, Share Premium, Treasury Shares, Merger Reserve, Reserve of Exchange Differences on Translation, Other Reserves, and Retained Earnings.
Filing Stats: 334 words · 1 min read · ~1 pages · Grade level 14.3 · Accepted 2024-08-28 07:29:31
Filing Documents
- ptv-20240630.htm (6-K) — 161KB
- a991pressrelease.htm (EX-99.1) — 63KB
- a992interimmanagementrepor.htm (EX-99.2) — 175KB
- ptv-20240630_d2.htm (EX-99.3) — 882KB
- ptv-20240630_g1.jpg (GRAPHIC) — 2KB
- 0001782999-24-000004.txt ( ) — 7115KB
- ptv-20240630.xsd (EX-101.SCH) — 93KB
- ptv-20240630_cal.xml (EX-101.CAL) — 84KB
- ptv-20240630_def.xml (EX-101.DEF) — 365KB
- ptv-20240630_lab.xml (EX-101.LAB) — 660KB
- ptv-20240630_pre.xml (EX-101.PRE) — 512KB
- ptv-20240630_htm.xml (XML) — 1124KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PURETECH HEALTH PLC Date: August 28, 2024 By: /s/ Bharatt Chowrira Name: Bharatt Chowrira Title: Chief Executive Officer